← Back to Patent Explorer
US5876452A Expired / Lapsed US ⏱️ 0.0 years remaining

Biodegradable implant

Assignee: The University of Texas System
•
Filing: 1995-05-30
•
Granted: 1999-03-02
•
Expires: 2015-05-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Biodegradable, porous, polymeric implant material provides substantially continuous release of bioactive agent during in vivo use. Bioactive agent is initially released in amounts that are less than degradation rate of polymer, thereby promoting migration of cells into material. Later larger amounts of bioactive agent are released, thereby promoting differentiation of cells. Method of making material includes steps of applying vacuum temperature and consession to form pores. Implant material may be adapted for one phase implant (e.g., for bone or cartilage) or for two phase layered implant (e.g., for cartilage layer on top of bone layer).

Inventors

  • 👤 Kyriacos A. Athanasiou
  • 👤 Barbara D. Boyan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:29
CPC Classifications
A; A61; A61L; A61L31/00; A61L31/14; A61L31/148; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2/30; A61F2/30756; A61L31/146; A61F2/3094; A61F2/0077; A61F2002/0086; A61F2002/2817; A61F2002/2835; A61F2002/2839; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/30011; A61F2002/30014; A61F2002/30032; A61F2002/3006; A61F2002/30062; A61F2002/30108; A61F2002/30199; A61F2002/30224; A61F2002/30667; A61F2002/30677; A61F2/30767; A61F2002/3093; A61F2002/30971; A61F2210/00; A61F2210/0004; A61F2230/00; A61F2230/0063; A61F2230/0069; A61F2240/00; A61F2240/001; A61F2250/00; A61F2250/0014; A61F2250/0018; A61F2250/0023; A61F2250/003

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 49 words
A porous bioerodible tissue implant device comprising a bioerodible synthetic polymeric material having a uniform non-fibrous composition characterized in that said material has a predetermined uniform porosity and is adapted to be implanted during use into cartilage, said polymeric material having the stiffness and compressibility properties of said cartilage.
Claim 2
Dependent Claim 49 words
A porous bioerodible tissue implant device comprising a bioerodible synthetic polymeric material having a uniform non-fibrous composition characterized in that said material has a predetermined uniform porosity and is adapted to be implanted during use into cartilage, said polymeric material having the stiffness and compressibility properties of said cartilage.
Claim 3
Dependent Claim 59 words
A molded, porous bioerodible tissue implant device comprising a bioerodible polymeric material, said device having a uniform, substantially solid, composition throughout the volume enclosed by the implant, characterized in that said material has a predetermined uniform porosity and is adapted to be implanted during use into bone, said polymeric material having the stiffness and compressibility properties of said bone.
Claim 4
Dependent Claim 59 words
A molded, porous bioerodible tissue implant device comprising a bioerodible polymeric material, said device having a uniform, substantially solid, composition throughout the volume enclosed by the implant, characterized in that said material has a predetermined uniform porosity and is adapted to be implanted during use into bone, said polymeric material having the stiffness and compressibility properties of said bone.
Claim 5
Dependent Claim 21 words
An implant device of claim 1 having access sites for receiving growth of tissue therein comprising passages extending into the material.
Claim 6
Dependent Claim 21 words
An implant device of claim 2 having access sites for receiving growth of tissue therein comprising passages extending into the material.
Claim 7
Dependent Claim 26 words
An implant device of claim 1 having a growth factor, bioactive agent to induce, promote, or support tissue ingrowth and repair incorporated into said polymeric material.
Claim 8
Dependent Claim 26 words
An implant device of claim 2 having a growth factor, bioactive agent to induce, promote, or support tissue ingrowth and repair incorporated into said polymeric material.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-03-01 2002-08-31 2003-03-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-03-01 2006-08-31 2007-03-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-03-01 2010-08-31 2011-03-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag